| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/30/2002 | EP1252317A2 Human enzymes and polynucleotides encoding the same |
| 10/30/2002 | EP1252316A2 Gene cluster for everninomicin biosynthesis |
| 10/30/2002 | EP1252315A2 Method for the production of a protein |
| 10/30/2002 | EP1252314A4 Identification and expression of human kir5.1 |
| 10/30/2002 | EP1252314A2 Identification and expression of human kir5.1 |
| 10/30/2002 | EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 10/30/2002 | EP1252312A1 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252311A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 10/30/2002 | EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 10/30/2002 | EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 10/30/2002 | EP1252308A2 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 10/30/2002 | EP1252307A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 10/30/2002 | EP1252306A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr |
| 10/30/2002 | EP1252305A2 Full-length human cdnas encoding potentially secreted proteins |
| 10/30/2002 | EP1252304A2 Novel plant promoters and methods of use |
| 10/30/2002 | EP1252303A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252302A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 10/30/2002 | EP1252299A2 Aspartyl proteases |
| 10/30/2002 | EP1252298A2 Phosphodiesterases |
| 10/30/2002 | EP1252297A1 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252293A1 Liver tissue source |
| 10/30/2002 | EP1252292A2 Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby |
| 10/30/2002 | EP1252291A2 Flavobacterium heparinum expression system |
| 10/30/2002 | EP1252290A1 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252289A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252191A1 Antibodies to suberic acid crosslinkers and methods for using the same |
| 10/30/2002 | EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 10/30/2002 | EP1252188A2 G-protein coupled receptors |
| 10/30/2002 | EP1252187A2 Fil-1 theta dnas and polypeptides |
| 10/30/2002 | EP1252185A1 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 10/30/2002 | EP1252180A2 Virulence genes, proteins, and their use |
| 10/30/2002 | EP1252177A1 Ligand for vascular endothelial growth factor receptor |
| 10/30/2002 | EP1252176A2 Nucleic acids, proteins, and antibodies |
| 10/30/2002 | EP1252175A1 Antisense modulation of survivin expression |
| 10/30/2002 | EP1251963A2 Compositions and methods for performing biological reactions |
| 10/30/2002 | EP1251871A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 10/30/2002 | EP1251870A2 Novel use |
| 10/30/2002 | EP1251840A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 10/30/2002 | EP1251835A2 Closure of bacterial ghosts |
| 10/30/2002 | EP1251744A1 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
| 10/30/2002 | EP1251731A2 Protein kinase stress-related proteins and methods of use in plants |
| 10/30/2002 | EP1251730A1 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 10/30/2002 | EP1149280B1 Method and device for automated chromophore-assisted laser/light inactivation (cali) |
| 10/30/2002 | EP1140973A4 Protein-protein interactions in neurodegenerative disorders |
| 10/30/2002 | EP1133689A4 Method for diagnosing neoplasia |
| 10/30/2002 | EP1129176A4 Embryonic stem cells |
| 10/30/2002 | EP1092044A4 IMPROVED METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
| 10/30/2002 | EP1071952A4 I kappa b and enhanced green fluorescent fusion protein |
| 10/30/2002 | EP1047942A4 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors |
| 10/30/2002 | EP1017412A4 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease |
| 10/30/2002 | EP0954598A4 Screening assay for compounds stimulating somatostatin and insulin production |
| 10/30/2002 | EP0907887A4 Engineering affinity ligands for macromolecules |
| 10/30/2002 | EP0885298A4 Plastid transformation in arabidopsis thaliana |
| 10/30/2002 | EP0862740B1 Oncogene fusion protein peptide vaccines |
| 10/30/2002 | EP0777749B1 Coupled amplification and ligation method |
| 10/30/2002 | EP0699076B1 Otitis media vaccine |
| 10/30/2002 | EP0689552B1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 10/30/2002 | EP0630403B1 Methods for the regulation of plant fertility |
| 10/30/2002 | CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer |
| 10/30/2002 | CN1377423A Cellulose films for screening |
| 10/30/2002 | CN1377421A Method of improving gene transfer efficiency into plant cells |
| 10/30/2002 | CN1377420A Method of improving gene transfer efficiency into plant cells |
| 10/30/2002 | CN1377419A Method for regulating transcription of foreign genes |
| 10/30/2002 | CN1377418A Promoter for regulating expression of foreign genes |
| 10/30/2002 | CN1377417A Isolation and characterization of fiber-specific actin promoter from cotton |
| 10/30/2002 | CN1377416A Sink protein |
| 10/30/2002 | CN1377415A 疫苗组合物 Vaccine composition |
| 10/30/2002 | CN1377414A Self-cleaving RNA sequences and their use for the control of protein synthesis |
| 10/30/2002 | CN1377413A Process for producing transglutaminase |
| 10/30/2002 | CN1377412A Polypeptides |
| 10/30/2002 | CN1377411A BASB 119 polypeptide and polynucleotide from noraxella catarrhalis |
| 10/30/2002 | CN1377410A Nucleic acids and proteins from group B streptoccus |
| 10/30/2002 | CN1377409A MEG-1 protein |
| 10/30/2002 | CN1377408A The PRV-1 gene and use thereof |
| 10/30/2002 | CN1377407A Transformant producing secondary metabolite modified with functional group and novel biosynthesis genes |
| 10/30/2002 | CN1377406A Protease conjugates having sterically protected clip sites |
| 10/30/2002 | CN1377370A C-peptide for the improved production of insulin and insulin analogues |
| 10/30/2002 | CN1377369A Vaccine antigens of moraxella |
| 10/30/2002 | CN1377278A Prevention and treatment of amyloidogenic disease |
| 10/30/2002 | CN1377226A Method for reconstructing a non-human mammal embryo with foetal adult differentiated cells |
| 10/30/2002 | CN1377225A Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine |
| 10/30/2002 | CN1376798A Human acetylcholinesterase isomer protein (AR-ACHE) and its gene coding sequence |
| 10/30/2002 | CN1376797A Cinnamon acyl-CoA reductase gene associated with wheat stalk development |
| 10/30/2002 | CN1376796A Coding sequence of novel human protein and its preparing process and application |
| 10/30/2002 | CN1376795A Calmative peptide precursor gene of dark-chest wasp, polypeptide coded by it and its preparing process |
| 10/30/2002 | CN1376794A Hemolytic peptide precursor gene of Asian-African wasp aptoxin, polypeptide coded by it and its preparing process |
| 10/30/2002 | CN1376791A Polypeptide-5-phosphate D-ribulose 3-isomerase-25.08 and polynucleotide for coding it |
| 10/30/2002 | CN1376790A Polypeptide-topoisomerase-18.48 and polynucleotide for coding it |
| 10/30/2002 | CN1376789A Polypeptide-human phosphotriesterase -22 and polynucleotide for coding it |
| 10/30/2002 | CN1376788A Polypeptide-human tyrosine phosphatase -20.68 and polynucletoide for coding it |
| 10/30/2002 | CN1376787A Polypeptide-tyrosine protein kinase -58.32 and polynucleotide for coding it |
| 10/30/2002 | CN1376786A Polypeptide-human Ser/Thr protein kinase -36.08 and polynucletoide for coding it |
| 10/30/2002 | CN1376785A Polypeptide-thiamine pyrophosphate kinase -26.73 and polynucleotide for coding it |
| 10/30/2002 | CN1376784A Polypeptide-acetylgucosamine transferase GNT1-30.36 and polynucletoide for coding it |
| 10/30/2002 | CN1376782A Polypeptide-human histidine deacetylase-14.96 and polynucelotide for coding it |
| 10/30/2002 | CN1376781A Polypeptide-pyruvate phosphodehydrogenase -69.30 and polynucleotide for coding it |
| 10/30/2002 | CN1376780A Polypeptide-threonine synthetase-9.35 and polynucleotide for coding it |
| 10/30/2002 | CN1376778A Process for preparing human insulin by means of transgenic fungus |